1. Home
  2. NSPR vs MBBC Comparison

NSPR vs MBBC Comparison

Compare NSPR & MBBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo InspireMD Inc.

NSPR

InspireMD Inc.

BUY

Current Price

$0.46

Market Cap

38.9M

Sector

Health Care

ML Signal

BUY

Logo Marathon Bancorp Inc.

MBBC

Marathon Bancorp Inc.

SELL

Current Price

$14.50

Market Cap

44.1M

Sector

Finance

ML Signal

SELL

Company Overview

Basic Information
Metric
NSPR
MBBC
Founded
2005
1902
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
38.9M
44.1M
IPO Year
2009
2020

Fundamental Metrics

Financial Performance
Metric
NSPR
MBBC
Price
$0.46
$14.50
Analyst Decision
Buy
Analyst Count
3
0
Target Price
★ $3.33
N/A
AVG Volume (30 Days)
★ 108.5K
3.2K
Earning Date
11-03-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 3200.00
EPS
N/A
★ 0.66
Revenue
★ $2,310,000.00
N/A
Revenue This Year
$9.14
N/A
Revenue Next Year
$105.44
N/A
P/E Ratio
★ N/A
$22.27
Revenue Growth
N/A
★ N/A
52 Week Low
$0.46
$10.53
52 Week High
$2.41
$15.79

Technical Indicators

Market Signals
Indicator
NSPR
MBBC
Relative Strength Index (RSI) 24.56 34.71
Support Level N/A $14.16
Resistance Level $1.00 $15.39
Average True Range (ATR) 0.08 0.11
MACD -0.01 -0.05
Stochastic Oscillator 2.19 0.00

Price Performance

Historical Comparison
NSPR
MBBC

About NSPR InspireMD Inc.

InspireMD Inc is a United States-based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System. It generates the majority of the revenue from the sales of CGuard EPS, which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The Company has one operating and reporting segment that develops, manufactures, and markets products for the treatment of carotid artery disease and other vascular diseases, including the Company's proprietary CGuard stent platform.

About MBBC Marathon Bancorp Inc.

Marathon Bancorp Inc is a mid-tier holding company for Marathon Bank, a Wisconsin-chartered savings bank. The group operates as a community-oriented bank offering a variety of financial products and services to meet the needs of customers. The primary deposit products are demand deposits, savings, and certificates of deposits; and prime lending products are commercial real estate, commercial and industrial, construction, one-to-four-family residential, multifamily real estate, and consumer loans. The majority of the group's revenue comes from interest income on loans and debt securities.

Share on Social Networks: